Key facts
- · Type: New offering first sale 2025-10-31 · Amount sold: $905K · Total offering: $1.66M · SEC filing
- · Type: New offering first sale 2025-12-16 · Amount sold: $1.41M · Total offering: $2.50M · SEC filing
- · Type: Filing · SEC filing
Is DMC Biotechnologies, Inc. a real, registered company?
DMC Biotechnologies, Inc. is a registered filer with the SEC (CIK 1728411) and has filed since 2025-04-23. 3 filings are on record, the latest on 2025-12-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has DMC Biotechnologies, Inc. raised?
Its new offerings report $2.32M sold across 2 offerings, as its own filings state.
Run the free check on DMC Biotechnologies, Inc. →
BOULDER, COLORADO
Biotechnology
3
$2.32M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-12-30 | New offering first sale 2025-10-31 | $905K | $1.66M | SEC filing |
| 2025-12-30 | New offering first sale 2025-12-16 | $1.41M | $2.50M | SEC filing |
| 2025-04-23 | Filing | — | — | SEC filing |
Keep reading
More on DMC Biotechnologies, Inc. and the records around it.
DMC Biotechnologies, Inc. elsewhere on the record
- Form D filing Dec 2025
- Form D filing Dec 2025
Watch DMC Biotechnologies, Inc.
Get an email when DMC Biotechnologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with DMC Biotechnologies, Inc.?
Who to contact
- Jim Flatt — Executive Officer, Director
- Rob van der Meij — Director
- Josko Bobanovic — Director
- Doug Cameron — Director
- Alastair Cooper — Director
- Matthew Lipscomb — Director
- K'Lynne Johnson — Director
- Josh Yelen — Executive Officer
- Round: Form D filed 2025-12-30
- Amount sold: $905K
- Industry: Biotechnology
- Based: BOULDER, COLORADO
People listed
- Jim Flatt — Executive Officer, Director
- Rob van der Meij — Director
- Josko Bobanovic — Director
- Doug Cameron — Director
- Alastair Cooper — Director
- Matthew Lipscomb — Director
- K'Lynne Johnson — Director
- Josh Yelen — Executive Officer
- Filing: Form D filed 2025-12-30
- Amount sold: $905K
- Industry group: Biotechnology
- Based: BOULDER, COLORADO
- Entity type: Corporation
We'll show it in your MentionFox inbox when DMC Biotechnologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch DMC Biotechnologies, Inc. →Want the whole picture on DMC Biotechnologies, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on DMC Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DMC Biotechnologies, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from DMC Biotechnologies, Inc.'s own filings with the SEC. The people those filings name are on the team page.